A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Incyte Corporation
Incyte Corporation
Incyte Corporation
Incyte Corporation
Incyte Corporation
Hangzhou GluBio Pharmaceutical Co., Ltd.
Icahn School of Medicine at Mount Sinai
AbbVie
Fox Chase Cancer Center
Herlev Hospital
Novartis
Case Comprehensive Cancer Center
Mayo Clinic
Icahn School of Medicine at Mount Sinai
Eli Lilly and Company
Eli Lilly and Company
California Cancer Consortium
Eli Lilly and Company
Yale University
Alliance for Clinical Trials in Oncology
Children's Oncology Group
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northwestern University
Northwestern University
National Institutes of Health Clinical Center (CC)
Exelixis
NYU Langone Health
University of Arizona
Rutgers, The State University of New Jersey